Calin Galaseanu, recently appointed general manager of Novo Nordisk Hungary, elaborates on the country’s strong treatment paradigm for diabetes. He…

Multinational pharma company managers working abroad must adapt to new cultures and develop a deep understanding of local markets. Korea is no…

All country managers of multinational pharma companies need to strike the balance between having a global outlook and adapting to local culture. For…

Every generation of Novo Nordisk’s insulin portfolio is currently on the Thai Market and the affiliate is one of the fastest-growing pharma…

Industry players - from Big Pharma giants to small local startups - are bringing new, innovative solutions to market in Korea in order to try and…

Steve Profit, general manager of Novo Nordisk Taiwan, shares a newcomers’ perspective as a recent transplant to the market from the company’s…

Thailand is becoming an increasingly attractive location for pharma companies to conduct clinical trials, with multinationals such as Novo Nordisk and…

Diabetes affects more than eight percent of the Thai population, a number that is on the rise, and nearly half of these cases remain undiagnosed. In…

John Dawber, vice president and general manager of Novo Nordisk Thailand, offers his first impressions of the Thai market since moving from Japan.…

Niels Abel Bonde, general manager of Novo Nordisk Sweden, explains the strategic significance of the Swedish market as an innovation-driven…

Dr Göran A. Ando, former chairman of Novo Nordisk and a Swedish life sciences industry veteran, recently moved back to his home country after over 35…

Rana Azfar, vice-president & general manager of Novo Nordisk Korea offers his impressions of the Korean market since moving from Pakistan. Azfar…